Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yvonne Ziegler

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Antibiotics (Basel, Switzerland)|April 27, 2026
An Epidemiological Study on the Effectiveness of Nasturtium Herb and Horseradish Root (Angocin<sup>®</sup><i>Anti-Infekt N</i>) as well as Other Phytopharmaceuticals, Synthetic Products, and Antibiotics on the Course of Acute Upper Respiratory Tract Infection (aURTI)Nina Kassner, Meinolf Wonnemann, Yvonne Ziegler, et al.
Antibiotics (Basel, Switzerland)|October 25, 2024
Investigation into the Effectiveness of an Herbal Combination (Angocin<sup>®</sup><i>Anti-Infekt N</i>) in the Therapy of Acute Bronchitis: A Retrospective Real-World Cohort StudyNina Kassner, Meinolf Wonnemann, Yvonne Ziegler, et al.
Antibiotics (Basel, Switzerland)|November 27, 2024
Effectiveness of a Combination of Nasturtium Herb and Horseradish Root (Angocin<sup>®</sup><i>Anti-Infekt N</i>) Compared to Antibiotics in Managing Acute and Recurrent Urinary Tract Infections: A Retrospective Real-world Cohort StudyNina Kassner, Meinolf Wonnemann, Yvonne Ziegler, et al.
Cancers|December 24, 2021
Transcription Regulation and Genome Rewiring Governing Sensitivity and Resistance to FOXM1 Inhibition in Breast CancerYvonne Ziegler, Valeria Sanabria Guillen, Sung Hoon Kim, et al.
Breast Cancer Research and Treatment|October 1, 2020
Contrasting activities of estrogen receptor beta isoforms in triple negative breast cancerShunchao Yan, Parama Dey, Yvonne Ziegler, et al.
Cancers|September 23, 2020
Suppression of Tumor Growth, Metastasis, and Signaling Pathways by Reducing FOXM1 Activity in Triple Negative Breast CancerParama Dey, Alexander Wang, Yvonne Ziegler, et al.
Endocrinology|October 17, 2022
Estrogen Receptor Beta 1: A Potential Therapeutic Target for Female Triple Negative Breast CancerParama Dey, Alexander Wang, Yvonne Ziegler, et al.
Breast Cancer Research and Treatment|July 9, 2024
Resistance to FOXM1 inhibitors in breast cancer is accompanied by impeding ferroptosis and apoptotic cell deathSandeep Kumar, Yvonne Ziegler, Blake N Plotner, et al.
Biotechnology and Bioengineering|May 17, 2016
Cell migration and organization in three-dimensional in vitro culture driven by stiffness gradientDanielle Joaquin, Michael Grigola, Gubeum Kwon, et al.
NPJ Breast Cancer|February 12, 2026
JAK/STAT1-interferon-ISGylation networks in breast cancer resistance to inhibitors of FOXM1 and CDK4/6Yvonne Ziegler, Sandeep Kumar, Carlos M Saeh, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Antibiotics (Basel, Switzerland)|April 27, 2026
An Epidemiological Study on the Effectiveness of Nasturtium Herb and Horseradish Root (Angocin<sup>®</sup><i>Anti-Infekt N</i>) as well as Other Phytopharmaceuticals, Synthetic Products, and Antibiotics on the Course of Acute Upper Respiratory Tract Infection (aURTI)Nina Kassner, Meinolf Wonnemann, Yvonne Ziegler, et al.
Antibiotics (Basel, Switzerland)|October 25, 2024
Investigation into the Effectiveness of an Herbal Combination (Angocin<sup>®</sup><i>Anti-Infekt N</i>) in the Therapy of Acute Bronchitis: A Retrospective Real-World Cohort StudyNina Kassner, Meinolf Wonnemann, Yvonne Ziegler, et al.
Antibiotics (Basel, Switzerland)|November 27, 2024
Effectiveness of a Combination of Nasturtium Herb and Horseradish Root (Angocin<sup>®</sup><i>Anti-Infekt N</i>) Compared to Antibiotics in Managing Acute and Recurrent Urinary Tract Infections: A Retrospective Real-world Cohort StudyNina Kassner, Meinolf Wonnemann, Yvonne Ziegler, et al.
Cancers|December 24, 2021
Transcription Regulation and Genome Rewiring Governing Sensitivity and Resistance to FOXM1 Inhibition in Breast CancerYvonne Ziegler, Valeria Sanabria Guillen, Sung Hoon Kim, et al.
Breast Cancer Research and Treatment|October 1, 2020
Contrasting activities of estrogen receptor beta isoforms in triple negative breast cancerShunchao Yan, Parama Dey, Yvonne Ziegler, et al.
Cancers|September 23, 2020
Suppression of Tumor Growth, Metastasis, and Signaling Pathways by Reducing FOXM1 Activity in Triple Negative Breast CancerParama Dey, Alexander Wang, Yvonne Ziegler, et al.
Endocrinology|October 17, 2022
Estrogen Receptor Beta 1: A Potential Therapeutic Target for Female Triple Negative Breast CancerParama Dey, Alexander Wang, Yvonne Ziegler, et al.
Breast Cancer Research and Treatment|July 9, 2024
Resistance to FOXM1 inhibitors in breast cancer is accompanied by impeding ferroptosis and apoptotic cell deathSandeep Kumar, Yvonne Ziegler, Blake N Plotner, et al.
Biotechnology and Bioengineering|May 17, 2016
Cell migration and organization in three-dimensional in vitro culture driven by stiffness gradientDanielle Joaquin, Michael Grigola, Gubeum Kwon, et al.
NPJ Breast Cancer|February 12, 2026
JAK/STAT1-interferon-ISGylation networks in breast cancer resistance to inhibitors of FOXM1 and CDK4/6Yvonne Ziegler, Sandeep Kumar, Carlos M Saeh, et al.
Pageof 2